Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Proxy Solicitation & Information Statement 2016

Feb 4, 2016

6785_rns_2016-02-04_36314971-f1ff-498b-918c-ce19913faecc.htm

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

_________ false

C002����� ��"�2PublicEVOGENE LTD10185Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: [email protected] via MAGNA: 04/02/2016              Time of broadcast: 14:02 13:35:08

Company site: www.evogene.com

Reference: 2016-02-023281

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Evogene Proxy Statement & Proxy Card for the Special General Meeting of shareholders
Evogene_2016_SGM_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2016-02-019228
Previous names of reporting entity:
Date of revision of form structure: 31/01/2016
- - -
Name of the Signatory: : Shalem Merav , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: .
Gad Feinstein St. Telephone: 08-9311900 , Facsimile: 08-9466724 , E-mail: [email protected] 1